Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.
April 10, 2024
Share
Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd (SZSE:000504) from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd. for CNY 0.03 million on April 11, 2024.
Chongqing International Trust Co., Ltd. completed the acquisition of 10.8% stake in Landfar Bio-medicine Co., Ltd (SZSE:000504) from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd. on April 11, 2024.
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.